Open AccessSevere adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic review
Author(s) -
Simona Bota
Publication year - 2013
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v5.i3.120
Subject(s) - medicine , ribavirin , discontinuation , adverse effect , gastroenterology , cirrhosis , hepatitis c virus , neutropenia , hepatitis c , pegylated interferon , virus , immunology , chemotherapy
To identify severe adverse events (SAEs) leading to treatment discontinuation that occur during antiviral therapy in hepatitis C virus (HCV)-infected cirrhotic patients.